Maria Stenback
VP Intellectual Property at BioInvent International AB | Greater Malmö Metropolitan Area, Sweden
Maria Stenback’s Email & Phone Number
VerifiedFree account · No credit card · 5 profiles/month
VP Intellectual Property at BioInvent International AB in September 2022 - Present
IP Director at BioInvent International AB in April 2015 - September 2022
Staff Representative to Board of Directors at AWA in August 2012 - April 2015
Center for International Intellectual Property Studies - CEIPI, July 2026
Center for International Intellectual Property Studies - CEIPI, CEIPI Diploma, July 2026
Lund University, French, July 1992 to July 1994
BioInvent International AB (Nasdaq Stockholm: BINV) is a clinical-stage biotech company that discovers and develops novel and first-in-class immuno-modulatory antibodies for cancer therapy, with currently five drug candidates in six ongoing clinical programs in Phase 1/2 trials for the treatment of hematological cancer and solid tumors. The Company's validated, proprietary F.I.R.S.T™ technology platform identifies both targets and the antibodies that bind to them, generating many promising new immune-modulatory candidates to fuel the Company's own clinical development pipeline and providing licensing and partnering opportunities. The Company generates revenues from research collaborations and license agreements with multiple top-tier pharmaceutical companies, as well as from producing antibodies for third parties in the Company's fully integrated manufacturing unit. More information is available at www.bioinvent.com.
Discover more about BioInvent International ABProtein biochemist | PhD in infection biology | production of oncolytic viruses | Antibody discovery
Associate Professor (Docent) at Lund University
(September 2018 – Present)
Director Computational Biology at BioInvent International AB | Co-Founder at Queo Health
Co-Founder at Queo Health
(October 2022 – Present)
SVP Technical Operations at BioInvent International AB
SVP Technical Operations at BioInvent International AB
(January 2018 – Present)
Medical Director, APMMC | Tactical Biotech Advisor | Clinical Oncologist, Ph.D.
Medical Director at BioInvent International AB
(May 2024 – Present)
President and CEO at BioInvent International AB
UniTargetingResearch AS, a VC backed start up company in Bergen/Norway, has developed a unique technology for increasing protein production in mammalian cell systems for the GLP and GMP manufacturing process of recombinant proteins.
Chief Business Officer at BioInvent International AB
Octave Biotech Consulting assists biotech companies large and small with all their business development needs, including partnering strategies, due diligence, structuring and negotiating term sheets and legal agreements, financial modelling, non-dilutive financing for developm...
What is Maria Stenback email address?
Email Maria Stenback at [email protected] and [email protected]. This email is the most updated Maria Stenback's email found in 2026.
What is Maria Stenback phone number?
Maria Stenback phone number is +46709427364.
How to contact Maria Stenback?
To contact Maria Stenback send an email to [email protected] or [email protected]. If you want to call Maria Stenback try calling on +46709427364. (updated on November 30, 2025)
What company does Maria Stenback work for?
Maria Stenback works for BioInvent International AB.
What is Maria Stenback's role at BioInvent International AB?
Maria Stenback is VP Intellectual Property
What industry does Maria Stenback work in?
Maria Stenback works in the Pharmaceuticals industry.